KalVista raises $33 mln
KalVista Pharmaceuticals said Wednesday it raised $33 million in Series B financing. RA Capital Management led the round, which included Longwood Fund and Venrock. Novo A/S and SV Life Sciences also participated. KalVista, of the United Kingdom, is a pharmaceutical company.
22 July 2015•3 mins read
